For The Public
Our mission is to serve the public interest by regulating the profession of pharmacy to provide safe, competent pharmacy care in Saskatchewan.
The College promotes public safety in a number of ways:
- Promotes safe pharmacy practice through regulation and standards
- Ensure its members are qualified and meet all the requirements of licensure
- Provide a body for public complaints
Exempted Codeine Products (ECPs): Proposed Regulatory Bylaw Amendments: Public Consultation
The Saskatchewan College of Pharmacy Professionals (SCPP) is proposing bylaw amendments to end the storage and sale of low dosage, behind-the-counter Exempted Codeine Products (ECPs) by pharmacists.
- These changes mean that ECPs will no longer be stored or sold within Saskatchewan pharmacies after these bylaw amendments are approved.
- There is time before ECPs are removed from pharmacy shelves.
- ECPs will no longer be sold in Saskatchewan after approximately September 2019 (depending on approval of the proposed bylaw amendments by the Minister of Health).
- ECPs are found to have numerous health risks, including dependence, potential for overdose (even at low doses), acetaminophen toxicity, liver failure, slowed heart rate, gastric hemorrhage, renal impairment, life-threatening biochemical imbalances, respiratory depression and arrest, confusion, hallucinations, seizures, stomach pain, nausea, and death.
- There are safer nonprescription alternatives to ECPs, including acetaminophen and ibuprofen for pain, or dextromethorphan for coughs.
- Codeine will continue to be available to patients at higher dosage levels with a Physician’s prescription.
- Please click here for more information on these proposed bylaw amendments.
- If you have any questions or concerns with these proposed bylaw amendments, you may provide your feedback to: firstname.lastname@example.org by January 25, 2019.